Spero Therapeutics
SPRO
SPRO
87 hedge funds and large institutions have $338M invested in Spero Therapeutics in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 22 increasing their positions, 25 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
1.73% less ownership
Funds ownership: 58.87% → 57.14% (-1.7%)
12% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 25
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
Holders
87
Holding in Top 10
2
Calls
$2M
Puts
$1.21M
Top Buyers
| 1 | +$13.5M | |
| 2 | +$4.11M | |
| 3 | +$3.28M | |
| 4 |
WJWM
Williams Jones Wealth Management
New York
|
+$1.94M |
| 5 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
+$1.07M |
Top Sellers
| 1 | -$6.05M | |
| 2 | -$1.14M | |
| 3 | -$825K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$595K |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$449K |